Wnt4/β-catenin signaling pathway modulates balloon-injured carotid artery restenosis via disheveled-1

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 12, 2014, Pages 8421-8431

  Hua, Junyi ^a   Xu, Yun ^a   He, Yuzhou ^a   Jiang, Xuhong ^a   Ye, Wu ^a   Pan, Zhimin ^a  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Disheveled 1; Rat; Restenosis; Statin; Vascular smooth muscle cells; Wnt; catenin

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, RAT; DISHEVELLED PROTEINS; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; WNT4 PROTEIN; WNT4 PROTEIN, RAT;

ADVERSE EFFECTS; ANIMAL; CAROTID ARTERY INJURY; CELL CULTURE; DISEASE MODEL; GRAFT OCCLUSION; IMMUNOHISTOCHEMISTRY; METABOLISM; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSIOLOGY; RAT; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANGIOPLASTY, BALLOON; ANIMALS; BETA CATENIN; BLOTTING, WESTERN; CAROTID ARTERY INJURIES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GRAFT OCCLUSION, VASCULAR; IMMUNOHISTOCHEMISTRY; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; WNT SIGNALING PATHWAY; WNT4 PROTEIN;

EID: 84921517643     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-31.
2. Ozer N, Tangurek B, Firat F, Ozer S, Tartan Z, Ozturk R, Ozay B, Ciloglu F, Yilmaz H, Cam N. Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention. Heart Vessels 2008; 23: 75-82.
3. Patti G, Nusca A, Di Sciascio G. Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus. Am J Cardiol 2008; 102: 1328-34.
4. Sebio A, Kahn M, Lenz HJ. The potential of targeting wnt/beta-catenin in colon cancer. Expert Opin Ther Targets 2014; 18: 611-5.
5. Ramachandran I, Thavathiru E, Ramalingam S, Natarajan G, Mills WK, Benbrook DM, Zuna R, Lightfoot S, Reis A, Anant S, Queimado L. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Oncogene 2012; 31: 2725-37.
6. Slater SC, Koutsouki E, Jackson CL, Bush RC, Angelini GD, Newby AC, George SJ. R-cadherin: beta-catenin complex and its association with vascular smooth muscle cell proliferation. Arterioscler Thromb Vasc Biol 2004; 24: 1204-10.
7. Tsaousi A, Williams H, Lyon CA, Taylor V, Swain A, Johnson JL, George SJ. Wnt4/β-catenin signaling induces VSMC proliferation and is associated with intimal thickening. Circ Res 2011; 108: 427-36.
8. Kim W, Kim M, Jho EH. Wnt/Beta-catenin signalling: from plasma membrane to nucleus. Biochem J 2013; 450: 9-21.
9. Merki E, Zamora M, Raya A, Kawakami Y, Wang J, Zhang X, Burch J, Kubalak SW, Kaliman P, Izpisua Belmonte JC, Chien KR, Ruiz-Lozano P. Epicardial retinoid X receptor alpha is required for myocardial growth and coronary artery formation. Proc Natl Acad Sci U S A 2005; 102: 18455-60.
10. Quasnichka H, Slater SC, Beeching CA, Boehm M, Sala-Newby GB, George SJ. Regulation of smooth muscle cell proliferation by beta-catenin/T-Cell factor signaling involves modulation of cyclin D1 and P21 expression. Circ Res 2006; 99: 1329-37.
11. Corada M, Nyqvist D, Orsenigo F, Caprini A, Giampietro C, Taketo MM, Iruela-Arispe ML, Adams RH, Dejana E. The Wnt/beta-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signaling. Dev Cell 2010; 18: 938-49.
12. Gao C, Chen YG. Dishevelled: the hub of wnt signaling. Cell Signal 2010; 22: 717-27.
13. Liu D, Cui W, Liu B, Hu H, Liu J, Xie R, Yang X, Gu G, Zhang J, Zheng H. Atorvastatin Protects Vascular Smooth Muscle Cells from Tgf-Beta1-Stimulated Calcification by Inducing Autophagy Via Suppression of the Beta-Catenin Pathway. Cell Physiol Biochem 2014; 33: 129-41.
14. Shyu KG, Chen SC, Wang BW, Cheng WP, Hung HF. Mechanism of the inhibitory effect of atorvastatin on leptin expression induced by angiotensin ii in cultured human coronary artery smooth muscle cells. Clin Sci (Lond) 2012; 122: 33-42.
15. Kim YM, Kim IH, Nam TJ. Capsosiphon fulvescens glycoprotein inhibits ags gastric cancer cell proliferation by downregulating Wnt-1 signaling. Int J Oncol 2013; 43: 1395-401.
16. Terada K, Misao S, Katase N, Nishimatsu S, Nohno T. Interaction of wnt signaling with bmp/smad signaling during the transition from cell proliferation to myogenic differentiation in mouse myoblast-derived cells. Int J Cell Biol 2013; 2013: 616294.
17. Toivonen S, Lundin K, Balboa D, Ustinov J, Tamminen K, Palgi J, Trokovic R, Tuuri T, Otonkoski T. Activin A and Wnt-dependent specification of human definitive endoderm cells. Exp Cell Res 2013; 319: 2535-44.
18. Coluccia AM, Vacca A, Mireia L, Dunach M, Mologni L, Redaelli S, Bustos VH, Benati D, Pinna LA, Gambacorti-Passerini C. Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation. EMBO J 2007; 26: 1456-66.
19. Tsaousi A, Williams H, Lyon CA, Taylor V, Swain A, Johnson JL, George SJ. Wnt4/β-catenin signaling induces VSMC proliferation and is associated with intimal thickening. Circ Res 2011; 108: 427-36.
20. Hilker M, Längin T, Hake U, Schmid FX, Kuroczynski W, Lehr HA, Oelert H, Buerke M. Gene expression profiling of human stenotic aorto-coronary bypass grafts by cdna array analysis. Eur J Cardiothorac Surg 2003; 23: 620-5.
21. Chen J, Stahl A, Krah NM, Seaward MR, Dennison RJ, Sapieha P, Hua J, Hatton CJ, Juan AM, Aderman CM, Willett KL, Guerin KI, Mammoto A, Campbell M, Smith LE. Wnt signaling mediates pathological vascular growth in proliferative retinopathy. Circulation 2011; 124: 1871-81.
22. Ozasa Y, Akazawa H, Qin Y, Tateno K, Ito K, Kudo-Sakamoto Y, Yano M, Yabumoto C, Naito AT, Oka T, Lee JK, Minamino T, Nagai T, Kobayashi Y, Komuro I. Notch activation mediates angiotensin II-induced vascular remodeling by promoting the proliferation and migration of vascular smooth muscle cells. Hypertens Res 2013; 36: 859-65.
23. Rodrigues Díez R, Rodrigues-Díez R, Lavoz C, Rayego-Mateos S, Civantos E, Rodríguez-Vita J, Mezzano S, Ortiz A, Egido J, Ruiz-Ortega M. Statins inhibit angiotensin II/smad pathway and related vascular fibrosis, by a tgf-beta-independent process. PLoS One 2010; 5: e14145.
24. Chen L, Wu Q, Guo F, Xia B, Zuo J. Expression of Dishevelled-1 in wound healing after acute myocardial infarction: possible involvement in myofibroblast proliferation and migration. J Cell Mol Med 2004; 8: 257-64.
25. Park ES, Lee KP, Jung SH, Lee DY, Won KJ, Yun YP, Kim B. Compound K, an intestinal metabolite of ginsenosides, inhibits PDGF-BB-induced VSMC proliferation and migration through G1 arrest and attenuates neointimal hyperplasia afterarterial injury. Atherosclerosis 2013; 228: 53-60.
26. Wu B, Crampton SP, Hughes CC. Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 2007; 26: 227-39.
27. Molica F, Burger F, Thomas A, Staub C, Tailleux A, Staels B, Pelli G, Zimmer A, Cravatt B, Matter CM, Pacher P, Steffens S. Endogenous cannabinoid receptor CB1 activation promotes vascular smooth-muscle cell proliferation and neointima formation. J Lipid Res 2013; 54: 1360-8.
28. Kong J, Zhang J, Li L, Jiang G, Wang X, Liu X, Yu B. Urinary trypsin inhibitor reduced neointimal hyperplasia induced by systemic inflammation after balloon injury in rabbits. Inflamm Res 2013; 62: 173-9.